STM
Journals
—
Open Access
Special Issue
Topic

Emerging chemical, biological, and drug design concepts that are significant to pharmacology, ADMET, and drug delivery.

Guest Editor:

        • Abstract Submission Deadline : 30/11/2023

        Manuscript Submission Deadline : 25/12/2023

        [This article belongs to Special Issue Emerging chemical, biological, and drug design concepts that are significant to pharmacology, ADMET, and drug delivery. under section rrjobi, rrjobi in (rrjobi, rrjobi)]

        Special Issue Description

        To reduce investments and optimize lead compounds, drug discovery and development have increasingly relied on in vitro testing and silico predictions. Lipophilicity, solubility, and plasma stability are among the key parameters of absorption, distribution, metabolism, and excretion that can be determined in vitro. Such test systems aid in the evaluation of a compound’s pharmacological properties and serve as surrogates before in vivo testing and clinical trials. Conducting DMPK (Drug Metabolism and Pharmacokinetics) studies, also known as ADMET (Absorption, Distribution, Metabolism, Elimination, Toxicity) studies, is an important part of drug discovery and development. Computer-aided techniques are now used not only in discovering new lead compounds but also throughout the drug development process, where ADMET profiling and big data analytics add a new level of complexity to those systems.

        Editor Keywords

        ADMET, Drug Design, Pharmacokinetics, Drug Metabolism, In silico predictions

        Manuscript Submission information

        Manuscripts should be submitted online by registering and logging in to this link. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed.
        Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent on email address:[email protected] for announcement on this website.

        Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page.

        Participating journals:

        Journal Name

        Research & Reviews: A Journal of Bioinformatics, Research & Reviews: A Journal of Bioinformatics

        Abbrivation

        rrjobi, rrjobi

        ISSN

        2393-8722, 2393-8722

        Since

        APC

        950  $